Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus XR vs. Prograf in De Novo Kidney Transplant
NCT01187953Phase 3Completed
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Sep 2010
- Primary completion
- Mar 2013
- Countries
- 15
01
Overview
A Phase 3 trial of Envarsus XR in acute allograft rejection, sponsored by Veloxis Pharmaceuticals. Started Sep 2010; status: completed.
02
Drugs
Envarsus XR
03
Conditions
acute allograft rejection
Beyond the preview
Go deeper on NCT01187953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187953.